Article
NRF2 signaling is repressed in HPV-driven head and neck cancer and correlates with better prognosis: HPV-E6/E7 confers chemosensitivity by inhibiting NRF2
2022-04-05
Abstract excerpt
<h4>Background: </h4> To investigate the role of NRF2 signaling in conferring superior prognosis in patients with HPV positive (HPV +ve ) head & neck squamous cell carcinomas (HNSCC) compared to HPV negative (HPV -ve ) HNSCC and develop molecular markers for selection of HPV +ve HNSCC patients for treatment de-escalation trials. <h4>Methods: </h4>: We compared NRF2 activity ( NRF2 , KEAP1 , and NRF2-transcriptiona...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1ce761b4-5c1f-517e-99ba-51557ce8eb1b
- DOI
- 10.21203/rs.3.rs-1504099/v1
